Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

MARPLAN

ISOCARBOXAZID

Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview MARPLAN is listed in Drugs@FDA under application 011961 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ISOCARBOXAZID Form and strength TABLET;ORAL - 10MG Sponsor LIFSA DRUGS Submission history Latest submission status date: 2018-11-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview MARPLAN is listed in Drugs@FDA under application 011961 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ISOCARBOXAZID Form and strength TABLET;ORAL - 10MG Sponsor LIFSA DRUGS Submission history Latest submission status date: 2018-11-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
MARPLAN (ISOCARBOXAZID) | Drug Monograph | MedicHelpline